Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$209.01 - $232.56 $627 - $697
3 Added 7.89%
41 $9,000
Q4 2023

Feb 02, 2024

SELL
$197.69 - $227.29 $2,569 - $2,954
-13 Reduced 25.49%
38 $9,000
Q3 2023

Oct 27, 2023

SELL
$201.05 - $221.7 $201 - $221
-1 Reduced 1.92%
51 $10,000
Q2 2023

Jul 26, 2023

BUY
$211.93 - $241.33 $2,967 - $3,378
14 Added 36.84%
52 $13,000
Q1 2023

May 03, 2023

SELL
$213.32 - $257.83 $3,199 - $3,867
-15 Reduced 28.3%
38 $9,000
Q4 2022

Feb 07, 2023

BUY
$203.72 - $248.97 $3,055 - $3,734
15 Added 39.47%
53 $12,000
Q3 2022

Nov 09, 2022

SELL
$204.81 - $262.19 $1,638 - $2,097
-8 Reduced 17.39%
38 $8,000
Q2 2022

Aug 05, 2022

BUY
$213.86 - $277.87 $1,710 - $2,222
8 Added 21.05%
46 $11,000
Q1 2022

May 09, 2022

SELL
$259.82 - $298.18 $519 - $596
-2 Reduced 5.0%
38 $10,000
Q4 2021

Feb 08, 2022

BUY
$271.6 - $314.21 $10,864 - $12,568
40 New
40 $13,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.